![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | IC50 | 8.0 [1], 95.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | Ki | 3.8 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_ea0f5584ab0c621398ec482f268c656f.svg) | Oxymetazoline | Ki | 14.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_ebac36f7213da3162d29205ab4152aca.svg) | Prazosin | Ki | 540.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_822ed9ddbb0a07c5a21db2f3d121f745.svg) | Rauwolscine | Ki | 1.2 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_1a2ef0969fddb77e7c383253c8b871b7.svg) | Clonidine | IC50 | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_1a2ef0969fddb77e7c383253c8b871b7.svg) | Clonidine | Ki | 3.8 [1], 20.89 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_b1a69169af7ce803f34e08ec3e1a1109.svg) | Corynanthine | IC50 | 211000.0 [1], 340000.0 [2], 871000.0 [3], 1038000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_6bd8428f24df55bebd5446ef40e0614c.svg) | Brimonidine | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_6bd8428f24df55bebd5446ef40e0614c.svg) | Brimonidine | Ki | 1.41 [1], 2.4 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | Ki | 140.0 [1], 230.0 [2], 263.0 [3] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_fe5b71c159134e28218ac4ef54e8c715.svg) | 2-Methoxyidazoxan | Ki | 0.91 [1], 1.41 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_028b726b0bd4cfab1950425844ad1058.svg) | Epinephrine | IC50 | 8.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_028b726b0bd4cfab1950425844ad1058.svg) | Epinephrine | Ki | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | Ki | 51.0 [1], 160.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | Ki | 1.8 [1], 7.5 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 87.0 [1], 1100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_1702ec4e91a6e6ac7ec0735114adb8a6.svg) | Ziprasidone | Ki | 390.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_01a74ff12e6bf089ced324ef974b490e.svg) | Cisapride | IC50 | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_7b0a378e6eb6435a9af3ef94b5296f14.svg) | Idazoxan | Ki | 51.29 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_fc72f32b9e12a3aa0b45eaefef8dcd47.svg) | Medetomidine | IC50 | 2900.0 [1], 3300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_6cb3ea27fe013e7dda2c01a588aff4ff.svg) | Zotepine | Ki | 180.0 [1], 960.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_381958d5b20fb4ad8b6c29b7c9f64be2.svg) | 1,2,3,4-Tetrahydroisoquinoline-7-sulfonamide | Ki | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_df20649e63f6814da658fbc9fd2ea41a.svg) | 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_df20649e63f6814da658fbc9fd2ea41a.svg) | 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_5ded4b26387a4a368dd361ab7e692e9b.svg) | 4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole | IC50 | 0.0 [1], 4300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_760c3502a4edf61c27018ca53a36c234.svg) | 4-Amino-N-[(4R)-1-azatricyclo[3.3.1.03,7]nonan-4-yl]-5-chloro-2-methoxybenzamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_712d7bf3cb291229e4b03575585bc48f.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methylquinoxalin-6-amine | Ki | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_fca61421b152236f16e5a0ef02891e33.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-1,2,3,4-tetrahydroquinoxalin-6-amine | Ki | 6.8 [1], 9.6 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_df20108b51b3e9526d663e98292b0c90.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | Ki | 41.0 [1], 64.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_d810df092ee21f1e4fb4e9bfa0785200.svg) | 5-O-[2-[[(3S)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl-methylamino]ethyl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | IC50 | 1000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_13ca8a7707d990fde72fc2db625d91c5.svg) | Norepinephrine | Ki | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_a6698f43557c38e4224d4f3969fabb79.svg) | Phenylephrine | Ki | 390.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | Ki | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_e684ff905325760b5d18575644f1108f.svg) | Phentolamine | Ki | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_f2beac4f632265172541ae8f16f89706.svg) | Nicardipine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_10e671aa0c2e8af205d779ba113db7f0.svg) | Zafirlukast | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_0670ec52c0fe87acac95c68ab7833293.svg) | Moxonidine | Ki | 75.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_b3480c65a1186fd9366ffe990bf8519c.svg) | Apraclonidine | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_112cb7603ef103663fb2d68ed01dbedd.svg) | Sertindole | Ki | 1680.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_cff59dd686ac48dc984e2eb35145cf4a.svg) | Rilmenidine | Ki | 180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_b1ddc5a5237d227b689739fcd0fddf19.svg) | Ipsapirone | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_fc35ad40133c87c689c12ced31f1c658.svg) | Naphazoline hydrochloride | IC50 | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_c10a0bbe3a1aa34b93e693178697177e.svg) | Xylometazoline | Ki | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_4d69a9f7fd76a521a605565c2d04c873.svg) | Efaroxan | Ki | 51.29 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_ff8d4194409d8fceaa071169fcd4b4d4.svg) | GR-127935 | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_d2bd8032afa36c172d5f1610288b68e2.svg) | Vilazodone | IC50 | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_46c4a0c7b7dde2d0575704d60ab1d58b.svg) | 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | Ki | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_62b1606a046d7b39586970ac17b7fa8b.svg) | Benalfocin | Ki | 16.7 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_020bfd18b62edb34e2d72ec4e775483c.svg) | 6-Fluoronorepinephrine | Ki | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_3fa3d4d37c41431459e68909a80b5d41.svg) | 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_ef72d819c5956278765872e07e3da665.svg) | p-Iodoclonidine | IC50 | 1.5 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_404ee23e4ae97a72a8990c4ff78f508e.svg) | N-Desmethylolanzapine | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_ba90fc96e5b07ab009cbd1149ee63274.svg) | 4-(2-Amino-1-hydroxyethyl)-3-fluorobenzene-1,2-diol | Ki | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_455dfdf5442cebeb22671a40b6b4946f.svg) | [2-(5-Chloro-2-methyl-1H-indol-3-yl)-ethyl]-dimethyl-amine | Ki | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_a81e6269fd67046608b3ea38d46bc220.svg) | 3-(Hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide | Ki | 1400000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_d7bf1dff71cbe4dfa3d661dbf332ef2c.svg) | 5-Fluoro-2-(4-pyridin-2-yl-piperazin-1-ylmethyl)-1H-indole | Ki | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_120d2e96cdc5b0a8ce4a3c5c616a9765.svg) | 4-N-(4,5-Dihydro-1H-imidazol-2-yl)-1-N-[4-(4,5-dihydro-1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine | Ki | 57.54 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_8550f32f8947ba36fb004ba5612abed1.svg) | 7-Bromo-1,2,3,4-tetrahydro-3-(trifluoromethyl)-isoquinoline | Ki | 1000000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_9a2ba9ed71e5df9e4da29df18857da6b.svg) | Amino({4-[(4-{[amino(iminio)methyl]amino}phenyl)amino]phenyl}amino)methaniminium | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_b46a2577496f41af96e22052685ef08f.svg) | 3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_5ef851f33b564c4d0d60b927b3a30acc.svg) | 7-Iodo-1,2,3,4-tetrahydroisoquinoline | Ki | 220.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_92d614d5709d3419bee51012767bc3dd.svg) | 1-[2-(3,4-Dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine | Ki | 181.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_496609dc7da28b8b2e1e0d0fa41ea22f.svg) | 1H-Imidazole, 2-(2-fluoro-5-methylphenyl)-4,5-dihydro- | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_f08216d393e6742dc5d3126cf1d8d096.svg) | Guanidine, 4,4'-methylenediphenyldi- | Ki | 416.87 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_1c474c8de4a4766114e4ef3bffe62d15.svg) | N-[4-[[4-(4,5-Dihydro-1H-imidazol-2-ylamino)phenyl]methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine | Ki | 1.58 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_1a7aeb8e4fabe30be0f730e346d690b4.svg) | N-(2-Chloro-4-iodophenyl)-2-methyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 2500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_120ba70d1a630c1c6c057cd4ce39b9c8.svg) | 7-Nitro-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline | Ki | 1400000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_9b0c589795997223b1f6936d1aa3d72d.svg) | 3-Methyl-7-nitro-1,2,3,4-tetrahydroisoquinoline | Ki | 31000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_b6371eb98467455f168ea861c107f1bf.svg) | 2-[4-[4-(Diaminomethylideneamino)benzoyl]phenyl]guanidine | Ki | 6309.57 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_879031eea1b8dd56ab876cd63d79089f.svg) | 3-[2-(Azepan-1-yl)ethyl]-6-propyl-1,3-benzothiazol-2-one | Ki | 205.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_717c942ef24151ed13d5c88d77299f30.svg) | 2-Oxazolamine, 5-[(2-bromophenoxy)methyl]-4,5-dihydro- | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_c95d166103872b8b663c670e773ae049.svg) | Bis[4-(4,5-dihydro-1H-imidazol-2-ylamino)phenyl]methanone | Ki | 1584.89 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_97661845ae31eac8f066cbf961094f30.svg) | N-((Hexahydro-1H-pyrrolizin-1-yl)methyl)-6-chloroimidazo(1,2-a)pyridine-8-carboxamide hydrochloride | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_8df870d870f84611b93070c6318e049b.svg) | 6-Chloro-3-methyl-9-prop-2-enoxy-1,2,4,5-tetrahydro-3-benzazepine | Ki | 48.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_7f7e702fedb6c490ebcabbf47514367e.svg) | 3-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline | Ki | 400000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_af27d7583af96b28cfd3eb5fd665467b.svg) | 2-(1,4-Benzodioxan-6-ylamino)-2-imidazoline | Ki | 3.1 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_9d7c980dc40d092d16ba94ceb6b99015.svg) | 7-Methanesulfonyl-3-trifluoromethyl-1,2,3,4-tetrahydro-isoquinoline | Ki | 3900000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_fe12e38c8ba4d6e66f5eba1af87eab20.svg) | 3-Fluoro-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol | Ki | 66.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_7a6b3c4b9c922debb0ddb1ad7e1872fb.svg) | 2-(2,6-Dichloro-4-nitrophenylimino)imidazolidine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_1a25fd3b14cdd6366b9860277ee1d8db.svg) | 2-Hydroxymethyl Olanzapine | Ki | 783.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_a54295420de0c74beb2bfea6b88a2fd2.svg) | Imidazolidine, 2-(2-methylphenylimino)- | Ki | 7.8 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_3fa94b4ff7419a9ef7fd9a311c2125dc.svg) | 3-[2-[4-(2-Chlorophenyl)-1-piperazinyl]ethyl]-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione | Ki | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_670d90efafb8d54191179070c82c6efe.svg) | 7-Isoquinolinecarbonitrile, 1,2,3,4-tetrahydro-3-(trifluoromethyl)- | Ki | 2900000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_6abd8ccdfd9ba54356184da8ae908075.svg) | 4-[1-Hydroxy-2-(methylamino)ethyl]-5-fluoropyrocatechol | Ki | 9.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_85ba99d104b51292d7de50bc42a06031.svg) | (E)-N-[2-[2-(Dimethylamino)ethyl-methylamino]-4-methylquinolin-6-yl]-3-[4-(trifluoromethoxy)phenyl]prop-2-enamide | IC50 | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_aeec2b1015f4a5f941baba942983f99b.svg) | N-(Dicyclopropylmethyl)-2,3-dimethyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_dbe735681658a8a5f62a21419d241122.svg) | N-(2,6-Dichlorophenyl)-5-methyl-4,5-dihydro-1H-imidazol-2-amine | Ki | 1949.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_917b0e56ab8c5bc6c867f82ac0d61039.svg) | 2-Fluoro-3-[1-hydroxy-2-(methylamino)ethyl]phenol | Ki | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_66c5c973d262c7b2297b4444a380f6d9.svg) | Benzeneethanamine, 4-fluoro-beta,3-dihydroxy-N-methyl- | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_5773aaf1e7c2c2043e0054bceaf4f918.svg) | 1-[(Dimethylamino)methyl]-2,3-dihydro-1H-indene-4,5-diol | Ki | 25.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_34253f3c344806ff4700be3da7ae2e85.svg) | 1H-Indene-4,5-diol, 2,3-dihydro-1-[(methylamino)methyl]- | Ki | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_b6850c360a7a0e43321c9631954803aa.svg) | 1H-Indene-4,5-diol, 1-(aminomethyl)-2,3-dihydro- | Ki | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_ce2a62073b41edec09fd585603d7781c.svg) | 1-[(Dipropylamino)methyl]-2,3-dihydro-1H-indene-4,5-diol | Ki | 470.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_456a922f76bb78ee2004d33067425339.svg) | 1H-Indene-5,6-diol, 1-(aminomethyl)-2,3-dihydro- | Ki | 520.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_76995ddb60c862a9568754950aa4cb0b.svg) | N-[4-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)phenoxy]phenyl]-4,5-dihydro-1H-imidazol-2-amine | Ki | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_dedfed9b4f9313100780adaaa7b6b62b.svg) | N-[4-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)phenyl]sulfanylphenyl]-4,5-dihydro-1H-imidazol-2-amine | Ki | 18.2 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_29f7b0efcddd49be91fae691d5e9b169.svg) | Benzeneethanamine, 2-fluoro-beta,5-dihydroxy-N-methyl- | Ki | 230.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_37a2478f651fa58cec1a5d4270b44e5a.svg) | 2-[4-[4-(Diaminomethylideneamino)phenyl]sulfanylphenyl]guanidine | Ki | 269.15 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-2_f445c94e6eb9448f995cbab7b7539b4c.svg) | 7-Bromo-3-methyl-1,2,3,4-tetrahydroisoquinoline | Ki | 1100.0 [1] |